The highest prevalence of CHEK2 1100delC has been reported in familial non-BRCA1/2 families also harboring colon cancer cases (18%) and in some highly selected high-risk breast cancer families (9–11%) [9,15,16]. Here, CHEK2 is linked to malignant colon neoplasm.